Skip to content

TTRX TTRX Total Operating Expenses

Total Operating Expenses at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$118.52M+22.8%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$106.12M-6.5%

Other financials

Income statement

See full
Operating income-$1.2M-224%
Net income-$971.0K-196%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's total operating expenses?
TTRX (TTRX) reported total operating expenses of $1.25M in Q1 2026.
How has TTRX's total operating expenses changed year-over-year?
TTRX's total operating expenses increased by 223.7% year-over-year, from $385K to $1.25M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.